Cargando...
Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist
While up to 80% of patients with Hodgkin’s lymphoma (HL) are cured with first-line therapy, relapsed/refractory (R/R) disease remains a clinical challenge and is fatal for many young patients. HL is unique in that the tumor cells (Hodgkin Reed–Sternberg; HRS cells) are a small fraction (<1%) of t...
Gardado en:
| Publicado en: | Ther Adv Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501496/ https://ncbi.nlm.nih.gov/pubmed/31105921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719846451 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|